Based on clinical glioma specimen and unique patient-derived cell lines carrying the endogenous IDH1 mutation, we report that IDH1m astrocytomas specifically rely on cystathionine-γ-lyase (CSE, also known as cystathionase, CTH gene) to increase their cysteine pool for de novo GSH synthesis. This evidence concerns the gene IDH1 and central nervous system cancer.